Archive

Genitourinary Cancers Symposium Daily News Archive

The Genitourinary Cancers Symposium Daily News is the official news source for the Genitourinary Cancers Symposium, providing expert perspectives on controversial topics and session highlights. Articles include physician-authored “Expert Editorials” on current clinical issues in oncology, interviews with Meeting attendees, and recaps of key sessions and presentations. Content is current as of the Meeting date and may not reflect the most recent data.


February 12, 2018

 Several experts discussed imaging, biopsy, the use of active surveillance, and the preservation of renal function and other aspects of oncologic and functional follow-up.

Read more

February 10, 2018

Management of adrenal tumors can be challenging, and evidence regarding various areas of treatment is fairly limited. Several experts spoke about endocrinologic issues, as well as treatment of metastatic disease and surgical management of ACC and PCC during General Session 7.

Read more

February 10, 2018

Cytoreductive nephrectomy (CN) is associated with improved survival in patients with metastatic papillary renal cell carcinoma (RCC), according to a retrospective analysis. The advantage over no CN was seen even after adjustment for prognostic imbalances.

Read more

February 10, 2018

A case-control study found that survivors of testicular cancer who underwent chemotherapy have an increased expression of p16INK4a, which has been called a biomarker of aging, in certain immune cells.

Read more

February 10, 2018

In the field of muscle-invasive bladder cancer (MIBC), a number of questions have arisen in recent years that may change how the malignancy is diagnosed and managed.

Read more

February 9, 2018

A better understanding of the genomics of this malignancy, as well as improved imaging techniques and developments of new therapeutics, is pushing the evolution of the diagnosis and treatment of advanced prostate cancer.

Read more

February 9, 2018

Two placebo-controlled trials found that treatment of nonmetastatic castration-resistant prostate cancer with androgen signaling inhibitors (ASIs) delays the development of metastatic disease and may prolong survival.

Read more
February 1, 2018

Because of its chronic and progressive nature and high incidence rate, prostate cancer is especially responsive to palliative care interventions. However, because of its association with terminal illness and end-of-life care, palliative care is used less frequently in patients with prostate cancer.

Read more
February 1, 2018

The U.S. Food and Drug Administration and ASCO leveraged their combined knowledge for the third FDA-ASCO Semi-Annual Hematology and Oncology Fellows Day Workshop.

Read more
February 1, 2018

The phase III PROSELICA study, which assessed the noninferiority of cabazitaxel 20 mg/m2 versus C25 in post-docetaxel patients with mCRPC, confirmed the activity of cabazitaxel and demonstrated that a dose reduction retains significant clinical benefits for these patients.

Read more
February 1, 2018

Dr. Monika Joshi, a genitourinary medical oncologist with the Penn State Milton S. Hershey Medical center, is attending the GU Cancers Symposium for the fourth time. She shares why she continues to attend the Symposium and shares her advice with newer attendees.

Read more

February 1, 2018

Dr. Robert J. Motzer will discuss the development and approval of tyrosine-kinase inhibitors (TKIs) for renal cell carcinoma (RCC) during his keynote lecture on February 10, touching on pivotal trials and controversies.

Read more

February 1, 2018

Dr. Seth P. Lerner, the Beth and Dave Swalm Chair in Urologic Oncology at Baylor College of Medicine, will discuss the impact of The Cancer Genome Atlas on bladder cancer research and the oncology field as a whole during his keynote lecture on February 9.

Read more
February 1, 2018

ASCO now awards American Board of Internal Medicine MOC points to members of ASCO’s Quality Oncology Practice Initiative and QOPI Certification Program.

Read more
February 1, 2018

Dr. Jalil Ali and Dr. Layth Mula-Hussain are two of the oncologists determined to revive cancer care progress in Iraq.

Read more

February 1, 2018

Dr. Robert G. Bristow will discuss how an understanding of germline and somatic mutations in prostate cancer can influence treatment, as well as available diagnostic tests and research methods to guide treatment choice based on a patient’s genetic profile, during his keynote lecture.

Read more
February 1, 2018

Dr. David Cahn, who is attending the GU Cancers Symposium for the third year in a row, discusses why he continues to attend the Symposium and shares his advice for newer attendees.

Read more
February 1, 2018

Women in oncology aren’t ascending the leadership ladder at rates anywhere close to their male counterparts—and ASCO wants to fix that.

Read more
February 1, 2018

A new guideline from ASCO outlines best practices for cancer clinicians when communicating with patients and their loved ones.

Read more
February 1, 2018

Dr. Ravi Madan and Dr. James Gulley discuss the possible role of immunotherapy in treating prostate cancer.

Read more